| scholarly article | Q13442814 |
| P50 | author | Yoichiro Iwakura | Q56564114 |
| P2093 | author name string | James L Kreindler | |
| Jay K Kolls | |||
| Shean J Aujla | |||
| Joseph M Pilewski | |||
| Shahid Husain | |||
| Mingquan Zheng | |||
| Todd A Reinhart | |||
| Patricia J Dubin | |||
| Derek A Pociask | |||
| Mike M Myerburg | |||
| Carol A Mason | |||
| Yvonne R Chan | |||
| Florencia McAllister | |||
| Mingjian Fei | |||
| David J Askew | |||
| Jennifer Edeal | |||
| Kristi Gaus | |||
| P2860 | cites work | Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides | Q24303817 |
| Role of IL-17A, IL-17F, and the IL-17 receptor in regulating growth-related oncogene-alpha and granulocyte colony-stimulating factor in bronchial epithelium: implications for airway inflammation in cystic fibrosis | Q24605366 | ||
| Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells | Q27860460 | ||
| The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells | Q27860620 | ||
| Transforming growth factor-beta induces development of the T(H)17 lineage | Q28237370 | ||
| Cutting edge: interleukin 17 signals through a heteromeric receptor complex | Q28247130 | ||
| IL-22 increases the innate immunity of tissues | Q28276850 | ||
| Interleukin-17 family members and inflammation | Q28287876 | ||
| TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells | Q28296956 | ||
| Lipocalin 2-deficient mice exhibit increased sensitivity to Escherichia coli infection but not to ischemia-reperfusion injury | Q28591880 | ||
| IL-23 drives a pathogenic T cell population that induces autoimmune inflammation | Q29547525 | ||
| Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages | Q29547871 | ||
| Development, cytokine profile and function of human interleukin 17-producing helper T cells | Q29617131 | ||
| Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells | Q29618163 | ||
| IL-17 family cytokines and the expanding diversity of effector T cell lineages | Q29619361 | ||
| Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron | Q29619561 | ||
| Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells | Q29622847 | ||
| CD4+ T cells mediate abscess formation in intra-abdominal sepsis by an IL-17-dependent mechanism | Q30885696 | ||
| Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense | Q34087551 | ||
| IL-23 compensates for the absence of IL-12p70 and is essential for the IL-17 response during tuberculosis but is dispensable for protection and antigen-specific IFN-gamma responses if IL-12p70 is available | Q34432140 | ||
| Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae | Q34450323 | ||
| Antibody-independent, interleukin-17A-mediated, cross-serotype immunity to pneumococci in mice immunized intranasally with the cell wall polysaccharide | Q34492821 | ||
| Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells | Q34556912 | ||
| IL-23-dependent IL-17 production is essential in neutrophil recruitment and activity in mouse lung defense against respiratory Mycoplasma pneumoniae infection | Q34596743 | ||
| The role of IL-17 and family members in the pathogenesis of arthritis | Q35165972 | ||
| IL-12 and IL-23: master regulators of innate and adaptive immunity. | Q35951805 | ||
| Pneumonia in the solid organ transplant patient | Q36085182 | ||
| Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation | Q36291657 | ||
| Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis. | Q36641930 | ||
| Production of beta-defensins by human airway epithelia | Q36758628 | ||
| Cloning and characterization of IL-10-related T cell-derived inducible factor (IL-TIF), a novel cytokine structurally related to IL-10 and inducible by IL-9. | Q40902420 | ||
| Improved detection of simian immunodeficiency virus RNA by in situ hybridization in fixed tissue sections: combined effects of temperatures for tissue fixation and probe hybridization | Q45734981 | ||
| Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice | Q45876568 | ||
| IL-17 markedly up-regulates beta-defensin-2 expression in human airway epithelium via JAK and NF-kappaB signaling pathways | Q46156771 | ||
| Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore | Q51652773 | ||
| Growth and differentiation of mouse tracheal epithelial cells: selection of a proliferative population. | Q52547922 | ||
| TLR4 mediates vaccine-induced protective cellular immunity to Bordetella pertussis: role of IL-17-producing T cells. | Q53013441 | ||
| IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge | Q58518610 | ||
| Resident Vdelta1+ gammadelta T cells control early infiltration of neutrophils after Escherichia coli infection via IL-17 production | Q79984931 | ||
| Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system | Q80102518 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pneumonia | Q12192 |
| Gram-negative bacteria | Q632006 | ||
| P304 | page(s) | 275-281 | |
| P577 | publication date | 2008-02-10 | |
| P1433 | published in | Nature Medicine | Q1633234 |
| P1476 | title | IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia | |
| P478 | volume | 14 |
| Q39298755 | A Non-invasive and Technically Non-intensive Method for Induction and Phenotyping of Experimental Bacterial Pneumonia in Mice. |
| Q36159216 | A Novel Nuclear Function for the Interleukin-17 Signaling Adaptor Protein Act1. |
| Q45834194 | A Th17- and Th2-skewed cytokine profile in cystic fibrosis lungs represents a potential risk factor for Pseudomonas aeruginosa infection. |
| Q36075829 | A Toll-Like Receptor 5 Agonist Improves the Efficacy of Antibiotics in Treatment of Primary and Influenza Virus-Associated Pneumococcal Mouse Infections. |
| Q34895774 | A case-control study of pre-operative levels of serum neutrophil gelatinase-associated lipocalin and other potential inflammatory markers in colorectal cancer |
| Q48231667 | A catch-22: Interleukin-22 and cancer |
| Q35824636 | A comprehensive review of the nasal microbiome in chronic rhinosinusitis (CRS). |
| Q37012219 | A functional IL-13 receptor is expressed on polarized murine CD4+ Th17 cells and IL-13 signaling attenuates Th17 cytokine production |
| Q28299539 | A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity |
| Q37326649 | A novel IL-17-dependent mechanism of cross protection: respiratory infection with mycoplasma protects against a secondary listeria infection |
| Q42604117 | A novel immunoregulatory function for IL-23: Inhibition of IL-12-dependent IFN-γ production |
| Q48130689 | A novel, dual cytokine-secretion assay for the purification of human Th22 cells that do not co-produce IL-17A. |
| Q37222807 | A polymorphism of interleukin-22 receptor alpha-1 is associated with the development of childhood IgA nephropathy |
| Q38170180 | A tale of two cytokines: IL-17 and IL-22 in asthma and infection |
| Q35115394 | Absence of interleukin 22 affects the oral microbiota and the progression of induced periapical lesions in murine teeth. |
| Q30824694 | Acquired resistance to innate immune clearance promotes Klebsiella pneumoniae ST258 pulmonary infection. |
| Q92511318 | Activation of Resolution Pathways to Prevent and Fight Chronic Inflammation: Lessons From Asthma and Inflammatory Bowel Disease |
| Q51751177 | Activation of Type 3 innate lymphoid cells and interleukin 22 secretion in the lungs during Streptococcus pneumoniae infection. |
| Q36733472 | Activation of inflammasome signaling mediates pathology of acute P. aeruginosa pneumonia. |
| Q55270760 | Adaptive genetic variation at three loci in South African vervet monkeys (Chlorocebus pygerythrus) and the role of selection within primates. |
| Q27025806 | Adaptive immunity to fungi |
| Q37777543 | Aerobiology and inhalation exposure to biological select agents and toxins. |
| Q48152629 | Allergic Aspergillus Rhinosinusitis |
| Q34298356 | Allergic airway inflammation decreases lung bacterial burden following acute Klebsiella pneumoniae infection in a neutrophil- and CCL8-dependent manner |
| Q35551320 | An SNP selection strategy identified IL-22 associating with susceptibility to tuberculosis in Chinese |
| Q39000453 | An Update on Lymphocyte Subtypes in Asthma and Airway Disease |
| Q58081543 | An airway epithelial IL-17A response signature identifies a steroid-unresponsive COPD patient subgroup |
| Q37243055 | An overview of IL-17 function and signaling |
| Q27021598 | An update on the hyper-IgE syndromes |
| Q27491282 | Analysis of CD161 expression on human CD8+ T cells defines a distinct functional subset with tissue-homing properties |
| Q37404847 | Anthrax, toxins and vaccines: a 125-year journey targeting Bacillus anthracis |
| Q33631108 | Anti-LPS antibodies protect against Klebsiella pneumoniae by empowering neutrophil-mediated clearance without neutralizing TLR4 |
| Q24642507 | Anti-inflammatory and pro-inflammatory roles of TGF-beta, IL-10, and IL-22 in immunity and autoimmunity |
| Q38030546 | Anti-inflammatory effects of interleukin-19 in vascular disease |
| Q37727501 | Antimicrobial Activity of Mesenchymal Stem Cells: Current Status and New Perspectives of Antimicrobial Peptide-Based Therapies |
| Q35746474 | Association of Mucosal Organisms with Patterns of Inflammation in Chronic Rhinosinusitis |
| Q36549105 | Attenuated Airway Epithelial Cell Interleukin-22R1 Expression in the Infant Nonhuman Primate Lung |
| Q34135558 | Averting inflammation by targeting the cytokine environment |
| Q92875091 | Avoiding contact allergens: from basic research to the in vitro identification of contact allergens |
| Q91750747 | BCL6 corepressor contributes to Th17 cell formation by inhibiting Th17 fate suppressors |
| Q47135898 | Bacillus anthracis lethal toxin negatively modulates ILC3 function through perturbation of IL-23-mediated MAPK signaling. |
| Q33609732 | Bacterial flagellin stimulates Toll-like receptor 5-dependent defense against vancomycin-resistant Enterococcus infection. |
| Q37545473 | Bifidobacterium bifidum PRL2010 modulates the host innate immune response |
| Q38691962 | Biofilm-Induced Type 2 Innate Immunity in a Cystic Fibrosis Model of Pseudomonas aeruginosa. |
| Q38753752 | Biological and pathological activities of interleukin-22. |
| Q30385283 | Biology of interleukin-22. |
| Q37866633 | Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22. |
| Q41550051 | CD161(+)CD4(+) T cells are enriched in the liver during chronic hepatitis and associated with co-secretion of IL-22 and IFN-γ |
| Q34813153 | CD4 T cells: fates, functions, and faults |
| Q36622318 | CD4(+) T-cell subsets and host defense in the lung |
| Q37999790 | CD4⁺T cells: differentiation and functions |
| Q62565047 | CFTR-deficiency renders mice highly susceptible to cutaneous symptoms during mite infestation |
| Q36499693 | CX(3)CR1(+) macrophages support IL-22 production by innate lymphoid cells during infection with Citrobacter rodentium |
| Q35001976 | CXCL13 expression in the gut promotes accumulation of IL-22-producing lymphoid tissue-inducer cells, and formation of isolated lymphoid follicles |
| Q24628780 | CXCR5⁺ T helper cells mediate protective immunity against tuberculosis |
| Q28074182 | Cancers Related to Immunodeficiencies: Update and Perspectives |
| Q37548220 | Candida albicans airway exposure primes the lung innate immune response against Pseudomonas aeruginosa infection through innate lymphoid cell recruitment and interleukin-22-associated mucosal response |
| Q35360459 | Cellular Plasticity of CD4+ T Cells in the Intestine |
| Q33827914 | Characterization of IL-22 and antimicrobial peptide production in mice protected against pulmonary Cryptococcus neoformans infection |
| Q36013814 | Characterization of Th17 responses to Streptococcus pneumoniae in humans: comparisons between adults and children in a developed and a developing country |
| Q36923913 | Chlorine gas exposure increases susceptibility to invasive lung fungal infection |
| Q33642445 | Cigarette smoke-induced oxidative stress suppresses generation of dendritic cell IL-12 and IL-23 through ERK-dependent pathways |
| Q37265849 | Clinical consequences of targeting IL-17 and TH17 in autoimmune and allergic disorders |
| Q34421458 | Clinical disease caused by Klebsiella in 2 unrelated patients with interleukin 12 receptor beta1 deficiency |
| Q28308116 | Clinical manifestations, etiology, and pathogenesis of the hyper-IgE syndromes |
| Q36506092 | Cloning and characterization of rainbow trout interleukin-17A/F2 (IL-17A/F2) and IL-17 receptor A: expression during infection and bioactivity of recombinant IL-17A/F2 |
| Q43855252 | Co-expression of S. Typhi GroEL and IL-22 gene augments immune responses against Salmonella infection |
| Q43734294 | Colonic microbiota alters host susceptibility to infectious colitis by modulating inflammation, redox status, and ion transporter gene expression |
| Q89171057 | Common ground: shared risk factors for type 1 diabetes and celiac disease |
| Q36742533 | Common risk alleles for inflammatory diseases are targets of recent positive selection |
| Q42500332 | Comparison of interferon-γ-, interleukin (IL)-17- and IL-22-expressing CD4 T cells, IL-22-expressing granulocytes and proinflammatory cytokines during latent and active tuberculosis infection. |
| Q34420814 | Conserved natural IgM antibodies mediate innate and adaptive immunity against the opportunistic fungus Pneumocystis murina. |
| Q35928405 | Contrasting Roles of IL-22 and IL-17 in Murine Genital Tract Infection by Neisseria gonorrhoeae. |
| Q34681370 | Contribution of IL-17-producing gamma delta T cells to the efficacy of anticancer chemotherapy |
| Q37420149 | Controlled Mycobacterium tuberculosis infection in mice under treatment with anti-IL-17A or IL-17F antibodies, in contrast to TNFα neutralization. |
| Q37716155 | Conventional NK cells can produce IL-22 and promote host defense in Klebsiella pneumoniae pneumonia |
| Q33702970 | Counter-regulation of T cell effector function by differentially activated p38. |
| Q40600498 | Critical Role of IL-22/IL22-RA1 Signaling in Pneumococcal Pneumonia |
| Q37083768 | Crystallization and preliminary X-ray diffraction analysis of human IL-22 bound to its soluble decoy receptor IL-22BP. |
| Q37991748 | Current investigational drugs in psoriasis |
| Q33568552 | Cytokine inhibition in the treatment of COPD. |
| Q37326640 | Cytokine mediators of Th17 function |
| Q37754913 | Cytokine networks in the infected lung |
| Q34249937 | Cytokine requirements for the differentiation and expansion of IL-17A- and IL-22-producing human Vgamma2Vdelta2 T cells. |
| Q37133450 | Cytokine signaling modules in inflammatory responses |
| Q33983999 | Cytokine-mediated regulation of antimicrobial proteins |
| Q39028574 | Cytokines IL-17 and IL-22 in the host response to infection |
| Q38986062 | Cytokines and Chemokines in Mycobacterium tuberculosis Infection |
| Q36286343 | Cytotoxic effector functions of T cells are not required for protective immunity against fatal Rickettsia typhi infection in a murine model of infection: Role of TH1 and TH17 cytokines in protection and pathology |
| Q40312759 | Dectin-1-dependent interleukin-22 contributes to early innate lung defense against Aspergillus fumigatus. |
| Q37352441 | Defects in Jak-STAT-mediated cytokine signals cause hyper-IgE syndrome: lessons from a primary immunodeficiency |
| Q36742247 | Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3 |
| Q46905194 | Deficient Candida-specific T-helper 17 response during sepsis |
| Q37682642 | Development, regulation and functional capacities of Th17 cells |
| Q42025675 | Developmental regulation of Th17-cell capacity in human neonates |
| Q28573335 | Dexamethasone suppresses interleukin-22 associated with bacterial infection in vitro and in vivo |
| Q34424824 | Diabetes and immunity to tuberculosis |
| Q36509083 | Differential Requirements for IL-17A and IL-22 in Cecal versus Colonic Inflammation Induced by Helicobacter hepaticus. |
| Q90092715 | Differential effects of Th17 cytokines during the response of neutrophils to Burkholderia cenocepacia outer membrane protein A |
| Q33535840 | Differentiation, distribution and gammadelta T cell-driven regulation of IL-22-producing T cells in tuberculosis |
| Q33788735 | Directing traffic: IL-17 and IL-22 coordinate pulmonary immune defense |
| Q51770922 | Diseases that may benefit from manipulating the Th17 pathway. |
| Q35947424 | Distinct Contributions of Neutrophils and CCR2+ Monocytes to Pulmonary Clearance of Different Klebsiella pneumoniae Strains |
| Q40231414 | Distinct immune signatures in the colon of Crohn's disease and ankylosing spondylitis patients in the absence of inflammation |
| Q27010199 | Diversity of IL-17-producing T lymphocytes |
| Q57194260 | Dual Role of IL-22 in Allergic Airway Inflammation and its Cross-talk with IL-17A |
| Q37271763 | During acute experimental infection with the reticulotropic Trypanosoma cruzi strain Tulahuen IL-22 is induced IL-23-dependently but is dispensable for protection |
| Q38940192 | Dynamics of Th17 associating cytokines in Cryptosporidium parvum-infected mice |
| Q35196768 | Dynamics of lung defense in pneumonia: resistance, resilience, and remodeling. |
| Q41845753 | ES-62 protects against collagen-induced arthritis by resetting interleukin-22 toward resolution of inflammation in the joints |
| Q39373309 | ESAT-6- and CFP-10-specific Th1, Th22 and Th17 cells in tuberculous pleurisy may contribute to the local immune response against Mycobacterium tuberculosis infection |
| Q37200625 | Early gene expression changes induced by the bacterial superantigen staphylococcal enterotoxin B and its modulation by a proteasome inhibitor |
| Q33824093 | Early local immune defences in the respiratory tract |
| Q33728489 | Early production of IL-22 but not IL-17 by peripheral blood mononuclear cells exposed to live Borrelia burgdorferi: the role of monocytes and interleukin-1. |
| Q37382215 | Effect of exercise therapy on cytokine secretion in the saliva of bedridden patients |
| Q42519492 | Effects of myeloid differentiation primary response gene 88 (MyD88) activation on Helicobacter infection in vivo and induction of a Th17 response |
| Q33919428 | Elevated CO2 selectively inhibits interleukin-6 and tumor necrosis factor expression and decreases phagocytosis in the macrophage |
| Q30431530 | Elevated IL-17 produced by TH17 cells promotes myeloma cell growth and inhibits immune function in multiple myeloma |
| Q34481869 | Elevated expression of both mRNA and protein levels of IL-17A in sputum of stable Cystic Fibrosis patients |
| Q37360656 | Emergence of the Th17 pathway and its role in host defense. |
| Q37346684 | Emerging concepts and future challenges in innate lymphoid cell biology |
| Q35133818 | Endogenous IL-22 plays a dual role in arthritis: regulation of established arthritis via IFN-γ responses |
| Q40543475 | Endoplasmic reticulum chaperone gp96 in macrophages is essential for protective immunity during Gram-negative pneumonia |
| Q39013838 | Enhanced effect of BCG vaccine against pulmonary Mycobacterium tuberculosis infection in mice with lung Th17 response to mycobacterial heparin-binding hemagglutinin adhesin antigen |
| Q36043946 | Enhanced protection to Mycobacterium tuberculosis infection in IL-10-deficient mice is accompanied by early and enhanced Th1 responses in the lung |
| Q37843657 | Enteric pathogens and gut function: Role of cytokines and STATs |
| Q30398550 | Epigenetic and Transcriptomic Regulation of Lung Repair during Recovery from Influenza Infection. |
| Q34308070 | Epithelial IL-22RA1-mediated fucosylation promotes intestinal colonization resistance to an opportunistic pathogen |
| Q61811297 | Epithelial stratification shapes infection dynamics |
| Q36080691 | Epithelial-intrinsic IKKα expression regulates group 3 innate lymphoid cell responses and antibacterial immunity. |
| Q34998232 | Epstein Barr virus-induced 3 (EBI3) together with IL-12 negatively regulates T helper 17-mediated immunity to Listeria monocytogenes infection |
| Q36730400 | Essentials of Th17 cell commitment and plasticity |
| Q35329102 | Estradiol inhibits Th17 cell differentiation through inhibition of RORγT transcription by recruiting the ERα/REA complex to estrogen response elements of the RORγT promoter |
| Q35439899 | Ethanol impairs mucosal immunity against Streptococcus pneumoniae infection by disrupting interleukin 17 gene expression |
| Q28658598 | Evolving strategies for cancer and autoimmunity: back to the future |
| Q34649770 | Experimental human pneumococcal carriage augments IL-17A-dependent T-cell defence of the lung |
| Q48304416 | Expression of Th17 and Treg lymphocyte subsets in hypertrophied adenoids of children and its clinical significance |
| Q35647194 | Expression of interleukin-22 in Sjögren's syndrome: significant correlation with disease parameters |
| Q84567439 | Expression, purification and characterization of recombinant human interleukin-22 in Pichia pastoris |
| Q88159846 | Facilitation of IL-22 production from innate lymphoid cells by prostaglandin E2 prevents experimental lung neutrophilic inflammation |
| Q93015468 | Flagellin adjuvanted F1/V subunit plague vaccine induces T cell and functional antibody responses with unique gene signatures |
| Q37374943 | From interleukin-23 to T-helper 17 cells: human T-helper cell differentiation revisited |
| Q37396937 | Gammadelta T cells and Th17 cytokines in hypersensitivity pneumonitis and lung fibrosis |
| Q37619851 | Genetic deficiencies of innate immune signalling in human infectious disease |
| Q46444584 | Genetic origins of hyper-IgE syndrome |
| Q34454590 | Genetic polymorphisms and tissue expression of interleukin-22 associated with risk and therapeutic response of gastric mucosa-associated lymphoid tissue lymphoma |
| Q98894968 | Gingival crevicular fluid levels of Interleukin-22 (IL-22) and human β Defensin-2 (hBD-2) in periodontal health and disease : A correlative study |
| Q33792948 | Glycogen synthase kinase-3β stabilizes the interleukin (IL)-22 receptor from proteasomal degradation in murine lung epithelia |
| Q26822449 | Goblet cells and mucins: role in innate defense in enteric infections |
| Q37448373 | Group 3 innate lymphoid cells inhibit T-cell-mediated intestinal inflammation through aryl hydrocarbon receptor signaling and regulation of microflora. |
| Q38602944 | Group 3 innate lymphoid cells: regulating host-commensal bacteria interactions in inflammation and cancer |
| Q87628212 | Gut microbiota: Neonatal gut microbiota induces lung immunity against pneumonia |
| Q37152701 | Hallmarks of Tissue-Resident Lymphocytes |
| Q37987526 | Healing of intestinal inflammation by IL-22. |
| Q38294540 | Helper T-cell type 17 cytokines and immunity in the lung |
| Q52721482 | High-Fat Diet Increases HMGB1 Expression and Promotes Lung Inflammation in Mice Subjected to Mechanical Ventilation. |
| Q37285549 | Homeostatic regulation of blood neutrophil counts |
| Q37223366 | Homing in on acute graft vs. host disease: tissue-specific T regulatory and Th17 cells |
| Q34246158 | Host cytokine responses distinguish invasive from airway isolates of the Streptococcus milleri/anginosis group |
| Q37677020 | Host defenses against bacterial lower respiratory tract infection |
| Q90661533 | Host immunology and rational immunotherapy for carbapenem-resistant Klebsiella pneumoniae infection |
| Q34018436 | Host response transcriptional profiling reveals extracellular components and ABC (ATP-binding cassette) transporters gene enrichment in typhoid fever-infected Nigerian children |
| Q38167443 | Host-microbial interactions in patients with chronic rhinosinusitis |
| Q30785501 | Human Chorionic Gonadotropin Has Anti-Inflammatory Effects at the Maternal-Fetal Interface and Prevents Endotoxin-Induced Preterm Birth, but Causes Dystocia and Fetal Compromise in Mice |
| Q39345202 | Human IL-22 binding protein isoforms act as a rheostat for IL-22 signaling. |
| Q41813956 | Human Langerhans cells control Th cells via programmed death-ligand 1 in response to bacterial stimuli and nickel-induced contact allergy |
| Q42915172 | Human NKp44+IL-22+ cells and LTi-like cells constitute a stable RORC+ lineage distinct from conventional natural killer cells |
| Q37562266 | Human TH17 cells express a functional IL-13 receptor and IL-13 attenuates IL-17A production |
| Q33849531 | Hypothermia Promotes Interleukin-22 Expression and Fine-Tunes Its Biological Activity. |
| Q34423484 | ICON: chronic rhinosinusitis |
| Q24649009 | IL-1 acts directly on CD4 T cells to enhance their antigen-driven expansion and differentiation |
| Q37974986 | IL-10 and IL-10 receptor defects in humans. |
| Q37297787 | IL-10 deficiency unleashes an influenza-specific Th17 response and enhances survival against high-dose challenge |
| Q35685575 | IL-13 regulates Th17 secretion of IL-17A in an IL-10-dependent manner |
| Q39126069 | IL-17 Receptor Signaling in the Lung Epithelium Is Required for Mucosal Chemokine Gradients and Pulmonary Host Defense against K. pneumoniae. |
| Q21296685 | IL-17 and IL-22 in cerebrospinal fluid and plasma are elevated in Guillain-Barré syndrome |
| Q34545889 | IL-17 and Th17 cells in tuberculosis |
| Q34786724 | IL-17 contributes to cell-mediated defense against pulmonary Yersinia pestis infection |
| Q38514251 | IL-17 cytokines in immunity and inflammation |
| Q37809207 | IL-17 family member cytokines: regulation and function in innate immunity. |
| Q34193357 | IL-17 in protective immunity to intracellular pathogens |
| Q41890076 | IL-17 in the rheumatologist's line of sight |
| Q33815790 | IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice |
| Q36142154 | IL-17-induced Act1-mediated signaling is critical for cuprizone-induced demyelination |
| Q36985422 | IL-17-producing innate lymphoid cells are restricted to mucosal tissues and are depleted in SIV-infected macaques |
| Q37983096 | IL-17/IL-17 receptor system in autoimmune disease: mechanisms and therapeutic potential |
| Q46089935 | IL-17/Th17 in anti-fungal immunity: what's new? |
| Q38986139 | IL-17: overview and role in oral immunity and microbiome |
| Q30435495 | IL-17A controls IL-17F production and maintains blood neutrophil counts in mice |
| Q35228647 | IL-17A induces Pendrin expression and chloride-bicarbonate exchange in human bronchial epithelial cells |
| Q33810455 | IL-17A produced by gammadelta T cells plays a critical role in innate immunity against listeria monocytogenes infection in the liver |
| Q55378997 | IL-17A, IL-17RC polymorphisms and IL17 plasma levels in Tunisian patients with rheumatoid arthritis. |
| Q37396941 | IL-17A-expressing T cells are essential for bacterial clearance in a murine model of hypersensitivity pneumonitis |
| Q39394243 | IL-17A-mediated neutrophil recruitment limits expansion of segmented filamentous bacteria. |
| Q24293160 | IL-17C regulates the innate immune function of epithelial cells in an autocrine manner |
| Q49165257 | IL-17F Promotes Tissue Injury in Autoimmune Kidney Diseases. |
| Q35922094 | IL-17RA in Non-Hematopoietic Cells Controls CXCL-1 and 5 Critical to Recruit Neutrophils to the Lung of Mycobacteria-Infected Mice during the Adaptive Immune Response |
| Q33925313 | IL-17RA is required for CCL2 expression, macrophage recruitment, and emphysema in response to cigarette smoke |
| Q39459097 | IL-17RE is the functional receptor for IL-17C and mediates mucosal immunity to infection with intestinal pathogens |
| Q35920946 | IL-17a and IL-22 Induce Expression of Antimicrobials in Gastrointestinal Epithelial Cells and May Contribute to Epithelial Cell Defense against Helicobacter pylori |
| Q90255327 | IL-1RA regulates immunopathogenesis during fungal-associated allergic airway inflammation |
| Q91805933 | IL-20 receptor cytokines in autoimmune diseases |
| Q34148906 | IL-21 induces IL-22 production in CD4+ T cells. |
| Q36540978 | IL-22 Defect During Streptococcus pneumoniae Infection Triggers Exacerbation of Chronic Obstructive Pulmonary Disease |
| Q35928387 | IL-22 Protects Against Liver Pathology and Lethality of an Experimental Blood-Stage Malaria Infection |
| Q27301071 | IL-22 Protects against Tissue Damage during Cutaneous Leishmaniasis |
| Q38928473 | IL-22 Up-Regulates β-Defensin-2 Expression in Human Alveolar Epithelium via STAT3 but Not NF-κB Signaling Pathway |
| Q37328260 | IL-22 and inflammation: leukin' through a glass onion |
| Q37014920 | IL-22 dampens the T cell response in experimental malaria |
| Q51054891 | IL-22 defines a novel immune pathway of antifungal resistance. |
| Q40626615 | IL-22 exacerbates weight loss in a murine model of chronic pulmonary Pseudomonas aeruginosa infection |
| Q34364633 | IL-22 fate reporter reveals origin and control of IL-22 production in homeostasis and infection |
| Q45963493 | IL-22 in mucosal immunity. |
| Q37228800 | IL-22 in the endometriotic milieu promotes the proliferation of endometrial stromal cells via stimulating the secretion of CCL2 and IL-8 |
| Q38093227 | IL-22 in tissue-protective therapy |
| Q39692981 | IL-22 is essential for lung epithelial repair following influenza infection |
| Q37103799 | IL-22 is expressed by the invasive trophoblast of the equine (Equus caballus) chorionic girdle. |
| Q34608524 | IL-22 is mainly produced by IFNγ-secreting cells but is dispensable for host protection against Mycobacterium tuberculosis infection |
| Q33971114 | IL-22 is produced by innate lymphoid cells and limits inflammation in allergic airway disease |
| Q57194265 | IL-22 is produced by γC-independent CD25+ CCR6+ innate murine spleen cells upon inflammatory stimuli and contributes to LPS-induced lethality |
| Q41147927 | IL-22 is rapidly induced by Pathogen Recognition Receptors Stimulation in Bone-Marrow-derived Dendritic Cells in the Absence of IL-23. |
| Q39034933 | IL-22 modulates IL-17A production and controls inflammation and tissue damage in experimental dengue infection |
| Q33604771 | IL-22 negatively regulates Helicobacter pylori-induced CCL20 expression in gastric epithelial cells |
| Q89542834 | IL-22 produced by Th22 cells aggravates atherosclerosis development in ApoE-/- mice by enhancing DC-induced Th17 cell proliferation |
| Q33828316 | IL-22 production is regulated by IL-23 during Listeria monocytogenes infection but is not required for bacterial clearance or tissue protection |
| Q36652620 | IL-22 regulation of functional gene expression in salivary gland cells |
| Q37137988 | IL-22 secreted by decidual stromal cells and NK cells promotes the survival of human trophoblasts. |
| Q34406318 | IL-22 signaling contributes to West Nile encephalitis pathogenesis |
| Q33655332 | IL-22(+)CD4(+) T cells promote colorectal cancer stemness via STAT3 transcription factor activation and induction of the methyltransferase DOT1L |
| Q38081171 | IL-22, not simply a Th17 cytokine |
| Q91809872 | IL-22-binding protein exacerbates influenza, bacterial super-infection |
| Q40688722 | IL-22-induced antimicrobial peptides are key determinants of mucosal vaccine-induced protection against H. pylori in mice. |
| Q35399287 | IL-22-induced regulatory CD11b+ APCs suppress experimental autoimmune uveitis |
| Q34733135 | IL-22-producing CD4+ cells are depleted in actively inflamed colitis tissue |
| Q38079587 | IL-22: An Evolutionary Missing-Link Authenticating the Role of the Immune System in Tissue Regeneration |
| Q57492004 | IL-22: An Underestimated Player in Natural Resistance to Tuberculosis? |
| Q37393834 | IL-22: a critical mediator in mucosal host defense |
| Q44944229 | IL-22BP dictates characteristics of Peyer's patch follicle-associated epithelium for antigen uptake |
| Q36261228 | IL-22R Ligands IL-20, IL-22, and IL-24 Promote Wound Healing in Diabetic db/db Mice |
| Q92643914 | IL-22Ra1 is induced during influenza infection by direct and indirect TLR3 induction of STAT1 |
| Q37349727 | IL-23 and Th17 cytokines in intestinal homeostasis |
| Q37275024 | IL-23 induced in keratinocytes by endogenous TLR4 ligands polarizes dendritic cells to drive IL-22 responses to skin immunization |
| Q37366047 | IL-23 induces IL-22 and IL-17 production in response to Chlamydia muridarum genital tract infection, but the absence of these cytokines does not influence disease pathogenesis |
| Q38939468 | IL-23 is required for long-term control of Mycobacterium tuberculosis and B cell follicle formation in the infected lung |
| Q92760637 | IL-23-producing IL-10Rα-deficient gut macrophages elicit an IL-22-driven proinflammatory epithelial cell response |
| Q26830943 | IL-23/IL-17A Dysfunction Phenotypes Inform Possible Clinical Effects from Anti-IL-17A Therapies |
| Q38711141 | IL-24 Promotes Pseudomonas aeruginosa Keratitis in C57BL/6 Mouse Corneas |
| Q40103200 | IL-33 Signaling Regulates Innate IL-17A and IL-22 Production via Suppression of Prostaglandin E2 during Lung Fungal Infection. |
| Q42229349 | IL-6/Stat3-driven pulmonary inflammation, but not emphysema, is dependent on interleukin-17A in mice. |
| Q88683196 | IL22 Promotes Kras-Mutant Lung Cancer by Induction of a Protumor Immune Response and Protection of Stemness Properties |
| Q95660451 | Identification of Reference Genes in Chicken Intraepithelial Lymphocyte Natural Killer Cells Infected with Very-virulent Infectious Bursal Disease Virus |
| Q50041515 | Identification of an innate T helper type 17 response to intestinal bacterial pathogens. |
| Q35276001 | Immune modulatory effects of IL-22 on allergen-induced pulmonary inflammation |
| Q33621874 | Immunological Aspect of Radiation-Induced Pneumonitis, Current Treatment Strategies, and Future Prospects |
| Q37225474 | Immunological mechanisms behind the cystic fibrosis-ABPA link |
| Q37991394 | Immunomodulation for gastrointestinal infections. |
| Q37776837 | Inborn errors of mucocutaneous immunity to Candida albicans in humans: a role for IL-17 cytokines? |
| Q47280526 | Increased autophagic sequestration in adaptor protein-3 deficient dendritic cells limits inflammasome activity and impairs antibacterial immunity. |
| Q34634513 | Increased expression of IL-22 is associated with disease activity in Behcet's disease |
| Q37825597 | Inducible NO synthase and antibacterial host defence in times of Th17/Th22/T22 immunity |
| Q35754472 | Inducible innate resistance of lung epithelium to infection |
| Q91889502 | Induction of IL-22 protein and IL-22-producing cells in rainbow trout Oncorhynchus mykiss |
| Q33778264 | Induction of TGF-beta1 and TGF-beta1-dependent predominant Th17 differentiation by group A streptococcal infection |
| Q37688392 | Infection and apoptosis as a combined inflammatory trigger |
| Q36396866 | Inflammatory monocyte recruitment is regulated by interleukin-23 during systemic bacterial infection |
| Q47844444 | Influence of hypoxia-inducible factor 1α on dendritic cell differentiation and migration |
| Q35643199 | Influence of oral lactoferrin on Mycobacterium tuberculosis induced immunopathology. |
| Q42604162 | Influence of the transcription factor RORgammat on the development of NKp46+ cell populations in gut and skin |
| Q34764015 | Influenza A inhibits Th17-mediated host defense against bacterial pneumonia in mice |
| Q37604453 | Influenza A virus exacerbates Staphylococcus aureus pneumonia in mice by attenuating antimicrobial peptide production |
| Q35859321 | Influenza-induced type I interferon enhances susceptibility to gram-negative and gram-positive bacterial pneumonia in mice |
| Q33608575 | Innate IL-17-producing cells: the sentinels of the immune system |
| Q60954877 | Innate Immune Cell Suppression and the Link With Secondary Lung Bacterial Pneumonia |
| Q36422470 | Innate Immune Signaling Activated by MDR Bacteria in the Airway |
| Q42683314 | Innate Lymphoid Cells in Intestinal Inflammation |
| Q64255314 | Innate Lymphoid Cells in Mucosal Immunity |
| Q27002611 | Innate immune signaling in defense against intestinal microbes |
| Q36908615 | Innate lymphoid cells in the initiation, regulation and resolution of inflammation |
| Q34279451 | Innate lymphoid cells promote anatomical containment of lymphoid-resident commensal bacteria. |
| Q36645149 | Innate lymphoid cells: balancing immunity, inflammation, and tissue repair in the intestine. |
| Q42747718 | Innate-like function of memory Th17 cells for enhancing endotoxin-induced acute lung inflammation through IL-22 |
| Q33956973 | Insights into IBD Pathogenesis |
| Q89787324 | Insulin-like Growth Factor 1 Supports a Pulmonary Niche that Promotes Type 3 Innate Lymphoid Cell Development in Newborn Lungs |
| Q88691581 | Integrative Physiology of Pneumonia |
| Q38051328 | Interaction of the pathogenic mold Aspergillus fumigatus with lung epithelial cells |
| Q39076009 | Interferon Control of the Sterol Metabolic Network: Bidirectional Molecular Circuitry-Mediating Host Protection |
| Q27655546 | Interferon- Is Functionally an Interferon but Structurally Related to the Interleukin-10 Family |
| Q36108222 | Interferon-λ and interleukin 22 act synergistically for the induction of interferon-stimulated genes and control of rotavirus infection |
| Q60630406 | Interleukin (IL)-17A and IL-22-producing neutrophils in psoriatic skin |
| Q39314776 | Interleukin 17 is a chief orchestrator of immunity |
| Q37332692 | Interleukin 17-producing T helper cells in alloimmunity |
| Q33708468 | Interleukin 22 attenuated angiotensin II induced acute lung injury through inhibiting the apoptosis of pulmonary microvascular endothelial cells |
| Q35784100 | Interleukin 23 production by intestinal CD103(+)CD11b(+) dendritic cells in response to bacterial flagellin enhances mucosal innate immune defense. |
| Q40539825 | Interleukin 7 immunotherapy improves host immunity and survival in a two-hit model of Pseudomonas aeruginosa pneumonia |
| Q37680986 | Interleukin and interleukin receptor diversity: role of alternative splicing |
| Q41826464 | Interleukin-1 receptor-associated kinase M-deficient mice demonstrate an improved host defense during Gram-negative pneumonia |
| Q38034469 | Interleukin-10 and interleukin-10-receptor defects in inflammatory bowel disease |
| Q37199853 | Interleukin-17 Pathophysiology and Therapeutic Intervention in Cystic Fibrosis Lung Infection and Inflammation |
| Q37735334 | Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease |
| Q34739767 | Interleukin-17 contributes to generation of Th1 immunity and neutrophil recruitment during Chlamydia muridarum genital tract infection but is not required for macrophage influx or normal resolution of infection |
| Q37363266 | Interleukin-17 in host defence against bacterial, mycobacterial and fungal pathogens |
| Q35009321 | Interleukin-17 is required for T helper 1 cell immunity and host resistance to the intracellular pathogen Francisella tularensis |
| Q47689166 | Interleukin-17 regulates matrix metalloproteinase activity in human pulmonary tuberculosis. |
| Q42279685 | Interleukin-17-dependent CXCL13 mediates mucosal vaccine-induced immunity against tuberculosis |
| Q34309786 | Interleukin-17-mediated control of parasitemia in experimental Trypanosoma congolense infection in mice |
| Q64997334 | Interleukin-17D Promotes Pathogenicity During Infection by Suppressing CD8 T Cell Activity. |
| Q39610932 | Interleukin-21 induces the differentiation of human Tc22 cells via phosphorylation of signal transducers and activators of transcription |
| Q92881803 | Interleukin-22 (IL-22) Binding Protein Constrains IL-22 Activity, Host Defense, and Oxidative Phosphorylation Genes during Pneumococcal Pneumonia |
| Q33964145 | Interleukin-22 (IL-22) production by pulmonary Natural Killer cells and the potential role of IL-22 during primary influenza virus infection |
| Q96680272 | Interleukin-22 Inhibits Respiratory Syncytial Virus Production by Blocking Virus-Mediated Subversion of Cellular Autophagy |
| Q24658609 | Interleukin-22 ameliorates acute severe pancreatitis-associated lung injury in mice |
| Q37530484 | Interleukin-22 as a molecular adjuvant facilitates IL-17-producing CD8+ T cell responses against a HBV DNA vaccine in mice |
| Q43102028 | Interleukin-22 binding protein (IL-22BP) is constitutively expressed by a subset of conventional dendritic cells and is strongly induced by retinoic acid |
| Q52691346 | Interleukin-22 immunotherapy during severe influenza enhances lung tissue integrity and reduces secondary bacterial systemic invasion. |
| Q26752528 | Interleukin-22 in Graft-Versus-Host Disease after Allogeneic Stem Cell Transplantation |
| Q27687335 | Interleukin-22 in kidney injury and regeneration |
| Q36070332 | Interleukin-22 is elevated in lavage from patients with lung cancer and other pulmonary diseases |
| Q35780751 | Interleukin-22 is increased in multiple sclerosis patients and targets astrocytes |
| Q35841871 | Interleukin-22 is produced by invariant natural killer T lymphocytes during influenza A virus infection: potential role in protection against lung epithelial damages |
| Q40059573 | Interleukin-22 level is negatively correlated with neutrophil recruitment in the lungs in a Pseudomonas aeruginosa pneumonia model. |
| Q36478883 | Interleukin-22 modulates gut epithelial and immune barrier functions following acute alcohol exposure and burn injury |
| Q34411311 | Interleukin-22 predicts severity and death in advanced liver cirrhosis: a prospective cohort study |
| Q46118254 | Interleukin-22 produced by alveolar macrophages during activation of the innate immune response |
| Q35095074 | Interleukin-22 promotes T helper 1 (Th1)/Th17 immunity in chlamydial lung infection |
| Q84365414 | Interleukin-22 promotes human hepatocellular carcinoma by activation of STAT3 |
| Q36483525 | Interleukin-22 promotes intestinal-stem-cell-mediated epithelial regeneration |
| Q40688717 | Interleukin-22 protects against non-typeable Haemophilus influenzae infection: alteration during chronic obstructive pulmonary disease |
| Q64994747 | Interleukin-22 receptor 1 is expressed in multinucleated giant cells: A study on intestinal tuberculosis and Crohn's disease. |
| Q36911822 | Interleukin-22 reduces lung inflammation during influenza A virus infection and protects against secondary bacterial infection. |
| Q36745327 | Interleukin-22 reduces the severity of collagen-induced arthritis in association with increased levels of interleukin-10. |
| Q53139446 | Interleukin-22 regulates antimicrobial peptide expression and keratinocyte differentiation to control Staphylococcus aureus colonization of the nasal mucosa. |
| Q34453038 | Interleukin-22 regulates the complement system to promote resistance against pathobionts after pathogen-induced intestinal damage. |
| Q39320252 | Interleukin-22-Induced Antimicrobial Phospholipase A2 Group IIA Mediates Protective Innate Immunity of Nonhematopoietic Cells against Listeria monocytogenes. |
| Q80830002 | Interleukin-22: a sheep in wolf's clothing |
| Q35530956 | Interleukin-22: immunobiology and pathology |
| Q36108832 | Interleukin-22: implications for liver ischemia-reperfusion injury |
| Q40444654 | Interleukin-23 (IL-23), independent of IL-17 and IL-22, drives neutrophil recruitment and innate inflammation during Clostridium difficile colitis in mice |
| Q37033085 | Interleukin-23 orchestrates mucosal responses to Salmonella enterica serotype Typhimurium in the intestine |
| Q40313360 | Interleukin-23-mediated inflammation in Pseudomonas aeruginosa pulmonary infection. |
| Q37404716 | Interleukin-23/Th17 pathways and inflammatory bowel disease |
| Q35665393 | Interleukin-4 (IL-4) and IL-13 suppress excessive neutrophil infiltration and hepatocyte damage during acute murine schistosomiasis japonica |
| Q35717842 | Intestinal Microbiota of Mice Influences Resistance to Staphylococcus aureus Pneumonia. |
| Q38971101 | Intestinal commensal bacteria mediate lung mucosal immunity and promote resistance of newborn mice to infection |
| Q37845442 | Intestinal microbiota, evolution of the immune system and the bad reputation of pro-inflammatory immunity |
| Q34031527 | Involvement of CCR6/CCL20/IL-17 axis in NSCLC disease progression |
| Q42094104 | Involvement of the IL-23/IL-17 axis and the Th17/Treg balance in the pathogenesis and control of autoimmune arthritis |
| Q38369782 | Ixekizumab for treatment of psoriasis. |
| Q93211674 | Klebsiella pneumoniae infection biology: living to counteract host defences |
| Q26745802 | Klebsiella pneumoniae: Going on the Offense with a Strong Defense |
| Q34371338 | L-22 enhances the invasiveness of endometrial stromal cells of adenomyosis in an autocrine manner |
| Q47403907 | Lactobacillus plantarum Enhanced IL-22 Production in Natural Killer (NK) Cells That Protect the Integrity of Intestinal Epithelial Cell Barrier Damaged by Enterotoxigenic Escherichia coli |
| Q36016336 | Leukemia inhibitory factor signaling is required for lung protection during pneumonia |
| Q46239692 | Limited Presence of IL-22 Binding Protein, a Natural IL-22 Inhibitor, Strengthens Psoriatic Skin Inflammation |
| Q34646648 | Lipocalin 2 imparts selective pressure on bacterial growth in the bladder and is elevated in women with urinary tract infection |
| Q37257477 | Lipocalin 2 is required for pulmonary host defense against Klebsiella infection |
| Q34490941 | Lipocalin 2 regulates inflammation during pulmonary mycobacterial infections. |
| Q37401782 | Lipocalin-2 resistance confers an advantage to Salmonella enterica serotype Typhimurium for growth and survival in the inflamed intestine |
| Q35001902 | Liver is the major source of elevated serum lipocalin-2 levels after bacterial infection or partial hepatectomy: a critical role for IL-6/STAT3. |
| Q30412824 | Location of CD4+ T cell priming regulates the differentiation of Th1 and Th17 cells and their contribution to arthritis |
| Q27316093 | Loss of Function of Intestinal IL-17 and IL-22 Producing Cells Contributes to Inflammation and Viral Persistence in SIV-Infected Rhesus Macaques |
| Q41759033 | Low DEFB4 copy number and high systemic hBD-2 and IL-22 levels are associated with dermatophytosis |
| Q40091655 | Lung epithelial cells: therapeutically inducible effectors of antimicrobial defense |
| Q37783745 | Lymphoid tissue inducer cells and the evolution of CD4 dependent high-affinity antibody responses. |
| Q37594571 | Lymphoid tissue inducer cells: bridges between the ancient innate and the modern adaptive immune systems |
| Q37977138 | Lymphoid tissue inducer cells: innate cells critical for CD4+ T cell memory responses? |
| Q42144635 | Lymphoid tissue inducer cells: pivotal cells in the evolution of CD4 immunity and tolerance? |
| Q28727683 | Marking and quantifying IL-17A-producing cells in vivo |
| Q28238414 | Mast cells and neutrophils release IL-17 through extracellular trap formation in psoriasis |
| Q90723370 | Mechanical Ventilation Impairs IL-17 Cytokine Family Expression in Ventilator-Associated Pneumonia |
| Q52448914 | Mechanisms and Targeted Therapies for Pseudomonas aeruginosa Lung Infection. |
| Q35096758 | Mechanisms controlling Th17 cytokine expression and host defense |
| Q37641941 | Mechanisms of Cholera Toxin in the Modulation of TH17 Responses |
| Q35763089 | Mechanisms of rapid induction of interleukin-22 in activated T cells and its modulation by cyclosporin a. |
| Q36650805 | Membrane-bound IL-22 after de novo production in tuberculosis and anti-Mycobacterium tuberculosis effector function of IL-22+ CD4+ T cells |
| Q28245271 | Memory IL-22-producing CD4+ T cells specific for Candida albicans are present in humans |
| Q46165208 | Mice genetically inactivated in interleukin-17A receptor are defective in long-term control of Mycobacterium tuberculosis infection |
| Q36441742 | Microbial translocation across the GI tract |
| Q37727840 | Microparticles released by Listeria monocytogenes-infected macrophages are required for dendritic cell-elicited protective immunity |
| Q37264694 | Modeling Klebsiella pneumoniae pathogenesis by infection of the wax moth Galleria mellonella. |
| Q101051175 | Modelling early events in Mycobacterium bovis infection using a co-culture model of the bovine alveolus |
| Q51770929 | Modulation of Th17 development and function by activation of the aryl hydrocarbon receptor--the role of endogenous ligands. |
| Q49710668 | Molecular characteristics of rhesus macaque interleukin-22: cloning, in vitro expression and biological activities. |
| Q37273205 | Molecular explanation for the contradiction between systemic Th17 defect and localized bacterial infection in hyper-IgE syndrome |
| Q38144077 | Molecular mechanisms and cell targets of Th17 cells in the gastrointestinal tract: an innate sense of adaptivity. |
| Q91307598 | Molecular signature of interleukin-22 in colon carcinoma cells and organoid models |
| Q51770957 | Mouse Th17 cells: current understanding of their generation and regulation. |
| Q49551961 | Mucocutaneous IL-17 immunity in mice and humans: host defense vs. excessive inflammation. |
| Q27010562 | Mucocutaneous candidiasis: the IL-17 pathway and implications for targeted immunotherapy |
| Q37415460 | Mucosal pre-exposure to Th17-inducing adjuvants exacerbates pathology after influenza infection |
| Q27334516 | Multifunctional double-negative T cells in sooty mangabeys mediate T-helper functions irrespective of SIV infection |
| Q37718355 | Multiple hats for natural killers |
| Q33425939 | Multiplex Analysis of Serum Cytokines in Humans with Hantavirus Pulmonary Syndrome |
| Q41896588 | Mycobacteria bypass mucosal NF-kB signalling to induce an epithelial anti-inflammatory IL-22 and IL-10 response |
| Q44764762 | NK cells exacerbate the pathology of influenza virus infection in mice |
| Q36455293 | NK cells influence both innate and adaptive immune responses after mucosal immunization with antigen and mucosal adjuvant. |
| Q35980771 | NLRC4 inflammasome-mediated production of IL-1β modulates mucosal immunity in the lung against gram-negative bacterial infection |
| Q41374805 | Nasal immunization with M cell-targeting ligand-conjugated ApxIIA toxin fragment induces protective immunity against Actinobacillus pleuropneumoniae infection in a murine model |
| Q37568931 | Natural killer (NK) and NK-like cells at mucosal epithelia: Mediators of anti-microbial defense and maintenance of tissue integrity |
| Q37706595 | Neutrophils recruited by IL-22 in peripheral tissues function as TRAIL-dependent antiviral effectors against MCMV. |
| Q36288405 | New Approaches for Studying Alcoholic Liver Disease |
| Q34175958 | New insights into T cell biology and T cell-directed therapy for autoimmunity, inflammation, and immunosuppression |
| Q90446129 | Nicotine Impairs the Response of Lung Epithelial Cells to IL-22 |
| Q35327027 | Nitric oxide sustains IL-1β expression in human dendritic cells enhancing their capacity to induce IL-17-producing T-cells |
| Q59134894 | Nonclinical safety assessment of a human interleukin-22FC IG fusion protein demonstrates in vitro to in vivo and cross-species translatability |
| Q40094981 | Nongenetically modified Lactococcus lactis-adjuvanted vaccination enhanced innate immunity against Helicobacter pylori. |
| Q33778205 | Notch signaling drives IL-22 secretion in CD4+ T cells by stimulating the aryl hydrocarbon receptor. |
| Q92875084 | Novel key cytokines in allergy: IL-17, IL-22 |
| Q38936163 | Novel role for IL-22 in protection during chronic Mycobacterium tuberculosis HN878 infection. |
| Q46089932 | Novel therapeutic targets along the Th17 pathway |
| Q37948124 | OX40 and CD30 signals in CD4(+) T-cell effector and memory function: a distinct role for lymphoid tissue inducer cells in maintaining CD4(+) T-cell memory but not effector function |
| Q91312483 | PAD4-dependent NETs generation are indispensable for intestinal clearance of Citrobacter rodentium |
| Q97423512 | Participation of the IL-10RB Related Cytokines, IL-22 and IFN-λ in Defense of the Airway Mucosal Barrier |
| Q34802944 | Pathogenesis of allergic bronchopulmonary aspergillosis in cystic fibrosis: current understanding and future directions. |
| Q37487728 | Pathogenesis of hyper IgE syndrome |
| Q24597173 | Pathological versus protective functions of IL-22 in airway inflammation are regulated by IL-17A |
| Q26771860 | Pathophysiology of chronic rhinosinusitis, pharmaceutical therapy options |
| Q36368544 | Patients with cystic fibrosis have inducible IL-17+IL-22+ memory cells in lung draining lymph nodes |
| Q37645889 | Perspectives on the etiology of chronic rhinosinusitis |
| Q38597444 | Phenotype and antimicrobial activity of Th17 cells induced by Propionibacterium acnes strains associated with healthy and acne skin |
| Q55445913 | Pivotal Role of IL-22 Binding Protein in the Epithelial Autoregulation of Interleukin-22 Signaling in the Control of Skin Inflammation. |
| Q38310232 | Plasticity of human CD4 T cell subsets |
| Q34318203 | Polyfunctional type-1, -2, and -17 CD8⁺ T cell responses to apoptotic self-antigens correlate with the chronic evolution of hepatitis C virus infection |
| Q36694323 | Potential role of ixekizumab in the treatment of moderate-to-severe plaque psoriasis |
| Q37630095 | Precarious balance: Th17 cells in host defense. |
| Q35563366 | Predominance of interleukin-22 over interleukin-17 at the site of disease in human tuberculosis |
| Q41999154 | Pro-Inflammatory Signaling by IL-10 and IL-22: Bad Habit Stirred Up by Interferons? |
| Q36948594 | Prostaglandin E2 synergistically with interleukin-23 favors human Th17 expansion |
| Q34270562 | Prostaglandin I2 signaling drives Th17 differentiation and exacerbates experimental autoimmune encephalomyelitis |
| Q37994635 | Proteases and the gut barrier. |
| Q35154329 | Protection against Streptococcus pneumoniae lung infection after nasopharyngeal colonization requires both humoral and cellular immune responses |
| Q26825858 | Protective and pathological properties of IL-22 in liver disease: implications for viral hepatitis |
| Q39704573 | Protective properties of inhaled IL-22 in a model of ventilator-induced lung injury. |
| Q40506767 | Protective role of IL-22 against Schistosoma mansoni soluble egg antigen-induced granuloma in Vitro. |
| Q38734006 | Protective role of Th17 cells in pulmonary infection |
| Q40477924 | Pseudomonas aeruginosa proteolytically alters the interleukin 22-dependent lung mucosal defense. |
| Q53691450 | Pulmonary Regnase-1 orchestrates the interplay of epithelium and adaptive immune systems to protect against pneumonia. |
| Q37018586 | Pulmonary Th17 Antifungal Immunity Is Regulated by the Gut Microbiome |
| Q34295528 | Quantitative RT-PCR profiling of the rabbit immune response: assessment of acute Shigella flexneri infection |
| Q64109976 | R. nukuhivensis acts by reinforcing skin barrier function, boosting skin immunity and by inhibiting IL-22 induced keratinocyte hyperproliferation |
| Q46167903 | RORγt+ innate lymphoid cells regulate intestinal homeostasis by integrating negative signals from the symbiotic microbiota |
| Q38972759 | RORγt, a multitask nuclear receptor at mucosal surfaces. |
| Q89305209 | Randomized Phase I Healthy Volunteer Study of UTTR1147A (IL-22Fc): A Potential Therapy for Epithelial Injury |
| Q36591501 | Rapamycin attenuates acute lung injury induced by LPS through inhibition of Th17 cell proliferation in mice |
| Q37851777 | Recent advances in IL-22 biology. |
| Q30419007 | Recent insights into pulmonary repair following virus-induced inflammation of the respiratory tract |
| Q38205440 | Recognition strategies of group 3 innate lymphoid cells |
| Q35662232 | Reduced IL-17A Secretion Is Associated with High Levels of Pneumococcal Nasopharyngeal Carriage in Fijian Children |
| Q35205539 | Redundant and pathogenic roles for IL-22 in mycobacterial, protozoan, and helminth infections |
| Q97525703 | Regeneration and repair in the healing lung |
| Q40209420 | Regionally compartmentalized resident memory T cells mediate naturally acquired protection against pneumococcal pneumonia. |
| Q37348457 | Regulation and function of proinflammatory TH17 cells |
| Q37442153 | Regulation of TH17 cells in the mucosal surfaces |
| Q37915047 | Regulation of Th17 cell differentiation by intestinal commensal bacteria |
| Q26864694 | Regulation of the adaptive immune system by innate lymphoid cells |
| Q54346247 | Regulation of the development of acute hepatitis by IL-23 through IL-22 and IL-17 production. |
| Q38190986 | Role of IL-23 in the pathogenesis of psoriasis: a novel potential therapeutic target? |
| Q63362830 | Role of MAIT cells in pulmonary bacterial infection |
| Q37622866 | Role of Th17 cells and IL-17 in lung transplant rejection |
| Q42150907 | Role of innate lymphocytes in infection and inflammation |
| Q34456769 | Role of interleukin-22 in inflammatory bowel disease |
| Q37263002 | Role of mucosal dendritic cells in inflammatory bowel disease |
| Q34127425 | Role of th17 cell and autoimmunity in chronic obstructive pulmonary disease |
| Q41863661 | Roles of interleukin-17 in an experimental Legionella pneumophila pneumonia model |
| Q35589806 | STAT3-Activating Cytokines: A Therapeutic Opportunity for Inflammatory Bowel Disease? |
| Q36888504 | STAT6 Signaling Attenuates Interleukin-17-Producing γδ T Cells during Acute Klebsiella pneumoniae Infection |
| Q64969864 | SU5416 attenuated lipopolysaccharide-induced acute lung injury in mice by modulating properties of vascular endothelial cells. |
| Q37774907 | Searching for novel intercellular signal-transducing molecules in the kidney and their clinical application |
| Q40683898 | Seasonal influenza A/H3N2 virus infection and IL-1Β, IL-10, IL-17, and IL-28 polymorphisms in Iranian population |
| Q48253677 | Sebocytes contribute to skin inflammation by promoting the differentiation of T helper 17 cells. |
| Q53637767 | Serum IL-17F combined with VEGF as potential diagnostic biomarkers for oral squamous cell carcinoma. |
| Q37040753 | Signaling via the IL-20 receptor inhibits cutaneous production of IL-1β and IL-17A to promote infection with methicillin-resistant Staphylococcus aureus |
| Q24648636 | Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine |
| Q33921803 | Stat3: linking inflammation to epithelial cancer - more than a "gut" feeling? |
| Q33601917 | Stimulated innate resistance of lung epithelium protects mice broadly against bacteria and fungi |
| Q37747165 | Structure and function of interleukin-22 and other members of the interleukin-10 family |
| Q24656543 | Structure of IL-22 bound to its high-affinity IL-22R1 chain |
| Q39370971 | Synergism between interleukin (IL)-17 and Toll-like receptor 2 and 4 signals to induce IL-8 expression in cystic fibrosis airway epithelial cells. |
| Q58121724 | T Cell-Intrinsic Receptor Interacting Protein 2 Regulates Pathogenic T Helper 17 Cell Differentiation |
| Q28395374 | T cell-mediated host immune defenses in the lung |
| Q37669790 | T helper 17 cells: discovery, function, and physiological trigger |
| Q35108903 | T helper cell subsets specific for Pseudomonas aeruginosa in healthy individuals and patients with cystic fibrosis |
| Q38134677 | T helper cells plasticity in inflammation. |
| Q45928617 | T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients. |
| Q37278356 | T-helper 17 lymphocytes in ocular cicatricial pemphigoid |
| Q39950912 | TGF-beta promotes Th17 cell development through inhibition of SOCS3. |
| Q28276449 | TH17 cells in development: an updated view of their molecular identity and genetic programming |
| Q38195597 | TLR Agonists as Modulators of the Innate Immune Response and Their Potential as Agents Against Infectious Disease. |
| Q46599011 | TLR2 deficiency by compromising p19 (IL-23) expression limits Th 17 cell responses to Mycobacterium tuberculosis |
| Q37268619 | TLR2 deficiency leads to increased Th17 infiltrates in experimental brain abscesses |
| Q34694834 | TLR5 signaling stimulates the innate production of IL-17 and IL-22 by CD3(neg)CD127+ immune cells in spleen and mucosa |
| Q35105613 | Tailored immune responses: novel effector helper T cell subsets in protective immunity |
| Q38047820 | Targeting IL-17 and TH17 cells in chronic inflammation |
| Q38633741 | Targeting IL-17 with ixekizumab in patients with psoriasis |
| Q37763951 | Targeting IL-23 in human diseases. |
| Q58562408 | Targeting IL22: a potential therapeutic approach for Kras mutant lung cancer? |
| Q38584529 | Targeting Th17 Effector Cytokines for the Treatment of Autoimmune Diseases |
| Q90617558 | Targeting the IL-22/IL-22BP axis enhances tight junctions and reduces inflammation during influenza infection |
| Q33894387 | Th 17 cells interplay with Foxp3+ Tregs in regulation of inflammation and autoimmunity |
| Q34038557 | Th1 and Th17 cells: adversaries and collaborators |
| Q36151179 | Th17 Cells Are More Protective Than Th1 Cells Against the Intracellular Parasite Trypanosoma cruzi |
| Q34432491 | Th17 Cells Coordinate with Th22 Cells in Maintaining Homeostasis of Intestinal Tissues and both are Depleted in SIV-Infected Macaques |
| Q34336840 | Th17 can regulate silica-induced lung inflammation through an IL-1β-dependent mechanism |
| Q38106558 | Th17 cell based vaccines in mucosal immunity |
| Q37106755 | Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis |
| Q33611067 | Th17 cells at the crossroads of innate and adaptive immunity against infectious diseases at the mucosa |
| Q34242697 | Th17 cells mediate clade-specific, serotype-independent mucosal immunity |
| Q36188911 | Th17 cells: critical mediators of host responses to burn injury and sepsis |
| Q37173921 | Th17 cells: from precursors to players in inflammation and infection |
| Q37576442 | Th17 cytokines and host-pathogen interactions at the mucosa: dichotomies of help and harm |
| Q33743570 | Th17 cytokines and the gut mucosal barrier |
| Q33792227 | Th17 cytokines and vaccine-induced immunity |
| Q33943805 | Th17 cytokines in mucosal immunity and inflammation |
| Q27335276 | Th17 effector cells support B cell responses outside of germinal centres |
| Q39426939 | Th17 profile in COPD exacerbations. |
| Q26861492 | Th17-mediated inflammation in asthma |
| Q37396933 | Th17-polarized immune response in a murine model of hypersensitivity pneumonitis and lung fibrosis |
| Q38068964 | Th22 and related cytokines in inflammatory and autoimmune diseases |
| Q42148408 | Th22 cells are an important source of IL-22 for host protection against enteropathogenic bacteria |
| Q37725429 | Th22 cells are associated with hepatocellular carcinoma development and progression |
| Q37224613 | Th22 cells control colon tumorigenesis through STAT3 and Polycomb Repression complex 2 signaling |
| Q24647357 | Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling |
| Q37850717 | Th22 in inflammatory and autoimmune disease: prospects for therapeutic intervention |
| Q37215886 | The Current STATus of lymphocyte signaling: new roles for old players. |
| Q37026138 | The Distribution and the Fibrotic Role of Elevated Inflammatory Th17 Cells in Patients With Primary Biliary Cirrhosis |
| Q35682867 | The Etiology and Pathogenesis of Chronic Rhinosinusitis: a Review of Current Hypotheses |
| Q35782202 | The Human IL-22 Receptor Is Regulated through the Action of the Novel E3 Ligase Subunit FBXW12, Which Functions as an Epithelial Growth Suppressor. |
| Q37697039 | The IL-17 family cytokines in immunity and disease. |
| Q28300826 | The IL-17 pathway as a major therapeutic target in autoimmune diseases |
| Q28252101 | The IL-20 subfamily of cytokines--from host defence to tissue homeostasis |
| Q37989164 | The IL-23/IL-17 pathway in inflammatory bowel disease |
| Q54216565 | The Immunoregulation of Th17 in Host against Intracellular Bacterial Infection. |
| Q55233965 | The Interleukin-20 Cytokine Family in Liver Disease. |
| Q40852964 | The N-glycan on Asn54 affects the atypical N-glycan composition of plant-produced interleukin-22, but does not influence its activity |
| Q36947949 | The Role of IL-22 in Viral Infections: Paradigms and Paradoxes |
| Q28070412 | The Role of Lymphocytes in Radiotherapy-Induced Adverse Late Effects in the Lung |
| Q34289823 | The Th1 immune response to Plasmodium falciparum circumsporozoite protein is boosted by adenovirus vectors 35 and 26 with a homologous insert |
| Q36713721 | The Th17 family: flexibility follows function. |
| Q37662888 | The Th17 pathway and inflammatory diseases of the intestines, lungs, and skin |
| Q36054539 | The Th17 pathway in cystic fibrosis lung disease. |
| Q59793706 | The Two-Faced Cytokine IL-6 in Host Defense and Diseases |
| Q38137012 | The aryl hydrocarbon receptor in innate T cell immunity |
| Q35713322 | The aryl hydrocarbon receptor regulates gut immunity through modulation of innate lymphoid cells |
| Q46470522 | The best defense is a good (Protease) offense: How Pseudomonas aeruginosa evades mucosal immunity in the lung |
| Q24614431 | The biological functions of T helper 17 cell effector cytokines in inflammation |
| Q35594963 | The changing face of asthma and its relation with microbes |
| Q35579076 | The current concept of T (h) 17 cells and their expanding role in systemic lupus erythematosus |
| Q37660167 | The cytokine IL-22 promotes pathogen colonization by suppressing related commensal bacteria. |
| Q56607716 | The dual nature of TH17 cells: shifting the focus to function |
| Q38797781 | The enigmatic role of IL-22 in asthma |
| Q47606845 | The expressions and roles of different forms of IL-22 in Mycobacterium tuberculosis infection. |
| Q24594675 | The interleukin-17 cytokine family: critical players in host defence and inflammatory diseases |
| Q38181085 | The multifaceted role of Th17 lymphocytes and their associated cytokines in cancer |
| Q35996059 | The multifaceted roles of neutrophil gelatinase associated lipocalin (NGAL) in inflammation and cancer |
| Q24321872 | The non-conventional MHC class I MR1 molecule controls infection by Klebsiella pneumoniae in mice |
| Q41948431 | The other T helper cells in asthma pathogenesis |
| Q89959893 | The protective efficacy of recombinant hypoxic response protein 1 of Nocardia seriolae in largemouth bass (Micropterus salmoides) |
| Q35484658 | The protective role of TLR6 in a mouse model of asthma is mediated by IL-23 and IL-17A. |
| Q37859621 | The role of IL-10 in immune regulation during M. tuberculosis infection |
| Q34151076 | The role of Th17 cytokines in primary mucosal immunity |
| Q38184626 | The role of innate and lymphoid IL-22-producing cells in the immunopathology of primary Sjögren's syndrome. |
| Q48146269 | The role of innate lymphoid cells in health and disease |
| Q26859112 | The role of nuclear hormone receptors in cutaneous wound repair |
| Q34126426 | The role of osteopontin (OPN/SPP1) haplotypes in the susceptibility to Crohn's disease |
| Q26750673 | The roles and functional mechanisms of interleukin-17 family cytokines in mucosal immunity |
| Q27691303 | The route less taken: pulmonary models of enteric Gram-negative infection |
| Q37830196 | The unexpected link between infection-induced apoptosis and a TH17 immune response. |
| Q41812432 | The β-glucan receptor dectin-1 promotes lung immunopathology during fungal allergy via IL-22. |
| Q36631313 | Therapeutic Role of Interleukin 22 in Experimental Intra-abdominal Klebsiella pneumoniae Infection in Mice. |
| Q38174792 | Therapeutic opportunities of the IL-22-IL-22R1 system |
| Q38407736 | Tissue-expressed B7-H1 critically controls intestinal inflammation |
| Q37733573 | Toll-like receptor 4-induced IL-22 accelerates kidney regeneration. |
| Q40050850 | Transcript profiling of the immunological interactions between Actinobacillus pleuropneumoniae serotype 7 and the host by dual RNA-seq. |
| Q46052625 | Transcription factor c-Maf mediates the TGF-β-dependent suppression of IL-22 production in T(H)17 cells. |
| Q37425866 | Transcriptional regulatory networks in Th17 cell differentiation |
| Q101038726 | Transcriptome analysis of chicken intraepithelial lymphocyte natural killer cells infected with very virulent infectious bursal disease virus |
| Q34984567 | Transcriptome profiling reveals Th17-like immune responses induced in zebrafish bath-vaccinated with a live attenuated Vibrio anguillarum |
| Q37511583 | Transition metal ions at the crossroads of mucosal immunity and microbial pathogenesis |
| Q26824855 | Treg cells: a potential regulator for IL-22 expression? |
| Q36338729 | Type 2 diabetes - Tuberculosis co-morbidity is associated with diminished circulating levels of IL-20 subfamily of cytokines |
| Q61807031 | Type 3 ILCs in Lung Disease |
| Q33619034 | Unexpected role for IL-17 in protective immunity against hypervirulent Mycobacterium tuberculosis HN878 infection. |
| Q34217243 | Unlike Th1, Th17 cells mediate sustained autoimmune inflammation and are highly resistant to restimulation-induced cell death |
| Q41273420 | Update in the mechanisms of allergen-specific immunotheraphy |
| Q36277359 | Vaccine-induced th17 cells are maintained long-term postvaccination as a distinct and phenotypically stable memory subset |
| Q39699269 | Variation in genes of β-glucan recognition pathway and susceptibility to opportunistic infections in HIV-positive patients |
| Q35557138 | Virus infection stages and distinct Th1 or Th17/Th22 T-cell responses in malaria/SHIV coinfection correlate with different outcomes of disease |
| Q92132713 | Vitamin D Induces Differential Effects on Inflammatory Responses During Bacterial and/or Viral Stimulation of Human Peripheral Blood Mononuclear Cells |
| Q35673174 | Vitamin D regulates cytokine patterns secreted by dendritic cells to promote differentiation of IL-22-producing T cells |
| Q34090830 | Vitamin D3 attenuates Th2 responses to Aspergillus fumigatus mounted by CD4+ T cells from cystic fibrosis patients with allergic bronchopulmonary aspergillosis |
| Q26767293 | Years in Review: Recent Progress in Cellular Allergology |
| Q36302839 | rIL-22 as an adjuvant enhances the immunogenicity of rGroEL in mice and its protective efficacy against S. Typhi and S. Typhimurium |
| Q40091484 | β-Carotene Biosynthesis in Probiotic Bacteria |
| Q34434443 | γδ T cells enhance autoimmunity by restraining regulatory T cell responses via an interleukin-23-dependent mechanism. |
| Q34161552 | γδ T cells protect against lung fibrosis via IL-22. |
Search more.